Goldman Sachs’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-30,616
| Closed | -$95K | – | 5787 |
|
|
2021
Q3 | $95K | Sell |
30,616
-20,681
| -40% | -$64.2K | ﹤0.01% | 5069 |
|
|
2021
Q2 | $191K | Buy |
51,297
+38,289
| +294% | +$143K | ﹤0.01% | 4932 |
|
|
2021
Q1 | $45K | Buy |
13,008
+2,529
| +24% | +$8.75K | ﹤0.01% | 5146 |
|
|
2020
Q4 | $35K | Sell |
10,479
-3,427
| -25% | -$11.4K | ﹤0.01% | 4591 |
|
|
2020
Q3 | $49K | Sell |
13,906
-14,611
| -51% | -$51.5K | ﹤0.01% | 4334 |
|
|
2020
Q2 | $131K | Sell |
28,517
-19,821
| -41% | -$91.1K | ﹤0.01% | 4108 |
|
|
2020
Q1 | $160K | Sell |
48,338
-68,075
| -58% | -$225K | ﹤0.01% | 4013 |
|
|
2019
Q4 | $711K | Buy |
116,413
+6,614
| +6% | +$40.4K | ﹤0.01% | 3493 |
|
|
2019
Q3 | $458K | Buy |
+109,799
| New | +$458K | ﹤0.01% | 3635 |
|